• BX Home
  • Merck & Co.: News [Page 3]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

MERCK & CO.

Merck & Co. Inc. is one of the largest pharmaceutical companies in the world. Drug treating high cholesterol, hypertension, and heart disease are among the company’s best-sellers. Merck also makes a broad range of drugs to treat other therapeutic areas, including Propencia for male pattern baldness; Singulair for asthma, and Fosamax for osteoporosis. Merck also creates vaccines for children and adults, most recently getting FDA approval for its cervical cancer vaccine Gardasil.

Merck & Co. is part of Business Exchange, suggested by Ginny Moore. This topic contains 967 news and 178 blog items. Read updated news, blogs, and resources about Merck & Co.. Find user-submitted articles and reactions on Merck & Co. from like-minded professionals.

News

Recent news on this topic.

EMD Serono President and CEO Fereydoun Firouz Resignsmore

(BUSINESS WIRE) -- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that Fereydoun...

UPDATE 1-Merck's hepatitis C drug recommended in Europemore

* European Medicines Agency recommends Victrelis * Merck drug to compete with Vertex's Incivek (Adds details,...

European Regulators Approve New Drugsmore

Adam Feuerstein Biotech Stock Mailbag: Cytori TherapeuticsASCO: Cancer Stock Winners, Losers Market Activity Biogen...

CHMP Issues Positive Opinion For Merck���s VICTRELISTM (boceprevir), O...more

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal...

EU agency backs Merck hep C, Bristol melanoma drugsmore

s Committee for Medicinal Products for Human Use (CHMP): Positive opinions for new medicines adopted: * Victrelis...

Sanofi���s Zerhouni On Translational Research: No Simple Solutionmore

Extract not available.

Takeda Pays ���Upper Limit��� for Nycomed as Competition Loomsmore

can Takeda digest this huge meal?��� said Reed Maurer, a former executive with Eli Lilly & Co. and Merck & Co.

Thermo Fisher to Buy Phadia for $3.5 Billionmore

billion. The deal followed a failed effort to acquire the laboratory equipment supplier Millipore, which was bought by...

Regulators reverse Fampyra decisionmore

also receive a double-digit percentage royalty. Approval in Europe triggers a $25 million milestone payment to Acorda.

UPDATE 2-US panel backs Abbott heart drug with new studymore

if adding a fibrate to a statin could reduce heart problems in diabetics. Patients were given TriCor with Merck &...

Critical Insider Trade Alerts For Alcoa, Merck, Marathon Oil, Central ...more

/PRNewswire-Asia/ -- Insiderslab.com today issued reports highlighted the respectable insider transactions for Alcoa,...

Thermo Fisher Agrees to Buy Phadia for $3.5 Billionmore

billion. The deal followed a failed effort to acquire the laboratory equipment supplier Millipore, which was bought by...

UPDATE 2-US panel backs Abbott heart drug with new studymore

if adding a fibrate to a statin could reduce heart problems in diabetics. Patients were given TriCor with Merck &...

US Intranasal Drug Delivery Industrymore

Consumer Care, Bespak Plc, GlaxoSmithKline Plc, Ikano Therapeutics Inc., Javelin Pharmaceuticals, Inc.

Takeda Buys Drugmaker Nycomed for $13.6 Billionmore

Laboratories loading...�� �� �� [FRX.N�� Loading...�� �� �� ()] has the marketing rights. In Europe, Merck & Co...

Thermo Fisher to pay ���2.47bn for Phadiamore

Extract not available.

Thermo Pursuing Phadiamore

Extract not available.

Drugmakers can't be sued on overcharge: U.S. Supreme Courtmore

to disrupt the $30 billion Medicaid program for outpatient prescription drugs. Among the companies appealing were...

UPDATE 3-Takeda to buy Swiss drugmaker Nycomed for $13.6 blnmore

some delays, it won U.S. approval in March where Forest Laboratories has the marketing rights. In Europe, Merck &...

UPDATE 2-Takeda to buy Swiss drugmaker Nycomed for $13.6 blnmore

some delays, it won U.S. approval in March where Forest Laboratories has the marketing rights. In Europe, Merck &...

UPDATE 1-Takeda says to buy Swiss drugmaker Nycomed for $13.6 blnmore

some delays, it won U.S. approval in March where Forest Laboratories has the marketing rights. In Europe, Merck &...

US and Europe escape worst of quake's aftershockmore

Extract not available.

Takeda to buy Nycomed for $13.6 billionmore

some delays, it won U.S. approval in March where Forest Laboratories has the marketing rights. In Europe, Merck &...

UPDATE 5-Takeda to buy Swiss drugmaker Nycomed for $13.7 blnmore

S. approval in March where Forest Laboratories (FRX.N: Quote, Profile, Research) has the marketing rights.

SciClone to Present New Preclinical Data on SCV-07 at 2011 ASCO Annual...more

such forward-looking statements. Ambien, Depakine and Stilnox are registered trademarks of Sanofi-Aventis.

Top Sources: Merck & Co.

  • Reuters
  • BusinessWeek
  • Philadelphia Inquirer
  • MarketWatch
  • Financial Times
  • Wall Street Journal Online
  • businesswire.com
  • latimes.com
  • Economictimes
  • inpharm.com

Most Active Users in this Topic

see all contributors in Merck & Co.

Featured White Papers

Post a Job

Jobs in this Topic

Reliability Engineer Job Merck | Elkton, VA
Posted: May 23
Merck Account Executive TransPerfect Careers | New York, NY
Posted: Oct 22
Lead Business Analyst - Merck Research Labs IT Job Merck | Rahway, NJ
Posted: May 23

Report comment contains invalid characters. ()
cancel
Search Cancel